Cargando…
Antibody-based Protection Against HIV Infection by Vectored ImmunoProphylaxis
Despite tremendous efforts, development of an effective vaccine against HIV has proved an elusive goal. Recently, however, numerous antibodies have been identified that are capable of neutralizing the vast majority of circulating HIV strains(1–5). These antibodies all exhibit an unusually high level...
Autores principales: | Balazs, Alejandro B., Chen, Joyce, Hong, Christin M., Rao, Dinesh S., Yang, Lili, Baltimore, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253190/ https://www.ncbi.nlm.nih.gov/pubmed/22139420 http://dx.doi.org/10.1038/nature10660 |
Ejemplares similares
-
Vectored ImmunoProphylaxis Protects Humanized Mice from Mucosal HIV Transmission
por: Balazs, Alejandro B., et al.
Publicado: (2014) -
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
por: Balazs, AB, et al.
Publicado: (2012) -
Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis
por: Phelps, Meredith, et al.
Publicado: (2021) -
AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020) -
Immunoprophylaxis against Mother-to-Child Transmission of HIV-1
por: Gorny, Miroslaw K, et al.
Publicado: (2006)